HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Crilvastatin

HCID 22845140
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
120551-59-9
Standard SMILES
CC1CC(OC(=O)[C@@H]2CCC(=O)N2)CC(C)(C)C1
InChIKey
FXAAOALUHHXBSO-ILDUYXDCSA-N
Molecular formula
C14H23NO3
Average molar mass
253.34 g/mol
Monoisotopic mass
253.1677936

Overview

Crilvastatin is a pyrrolidone non-competitive inhibitor of hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase. Crilvastatin acts by stimulating LDL-cholesterol uptake by hepatocytes and also by stimulating bile cholesterol and bile salt secretion.

Names & identifiers

Preferred name
Crilvastatin
IUPAC
(3,3,5-trimethylcyclohexyl) (2S)-5-oxopyrrolidine-2-carboxylate
English name
Crilvastatin
Molecular formula
C14H23NO3
Molecular weight
253.34

Names & synonyms

CRILVASTATIN120551-59-9CrilvastatinaCrilvastatineCrilvastatinumPMD-387D2B8XWK36KPMD387DTXSID1010094385-Oxo-L-proline, (+-)-cis-3,3,5-trimethylcyclohexyl esterRefChem:128460DTXCID401436268
Show more names
FXAAOALUHHXBSO-ILDUYXDCSA-NL-Proline, 5-oxo-, 3,3,5-trimethylcyclohexyl ester
(3,3,5-trimethylcyclohexyl) (2S)-5-oxopyrrolidine-2-carboxylatePMD 387Crilvastatin [USAN:INN]UNII-D2B8XWK36KCrilvastatine [INN-French]Crilvastatinum [INN-Latin]cyclopidCrilvastatina [INN-Spanish]

Database identifiers

CAS
120551-59-9
PubChem CID
22845140
DTXSID
DTXSID101009438
ChEMBL
CHEMBL2218880

Properties

Computed structural properties

XLogP
2.6
Topological polar surface area
55.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
3
Heavy atoms
18
Formal charge
0
Complexity
351

Physicochemical properties

Boiling point
389.865 · 389.865±35.00 °C(Press: 760.00 Torr)(predicted)
Density
1.09 · 1.090±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka
14.599 · 14.599±0.40(predicted)
FDA UNII
2 B8XWK36K · D2B8XWK36K

Chemistry & industry

Pharmacology

MeSH Pharmacological ClassificationCompounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis.

Applications

UsesAntihyperlipidemic.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes